Billionaire Stanley Druckenmiller Bought Amazon and Alphabet in Q2. But His Single Biggest Holding Is Neither of Them -- and It's Not Nvidia Either.
Natera's growth, expanding role in cancer care, and growing diagnostic data platform help explain why Druckenmiller has made it a major portfolio holding, despite valuation and regulatory risks.
Stanley Druckenmiller, the renowned billionaire macro investor, recently disclosed his latest 13F holdings, revealing that his largest investment was not in the expected tech giants like Amazon and Alphabet, nor in the high-flying Nvidia. Instead, a substantial portion of his portfolio was allocated to a genetic testing company named Natera (NASDAQ: NTRA), representing nearly one-fifth of his investments.
This unusual choice has caught the attention of observers, prompting them to question the reasoning behind Druckenmiller's decision to stake such a significant portion of his wealth in a mid-cap diagnostics firm. Natera specializes in molecular diagnostics, focusing on the analysis of minute DNA fragments found in blood to provide insights into various aspects of human health, including pregnancy, cancer, and organ function.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- Billionaire Stanley Druckenmiller Bought Amazon and Alphabet in Q2. But His Single Biggest Holding Is Neither of Them -- and It's Not Nvidia Either. finance.yahoo.com
- Billionaire Investor Stanley Druckenmiller Sold Broadcom, Intel, and Micron and Bought Another Chip Stock That Expects to Double Data Center Sales in 2027 fool.com
- Billionaire Stanley Druckenmiller Bought Amazon and Alphabet in Q2. But His Single Biggest Holding Is Neither of Them -- and It's Not Nvidia Either. nasdaq.com
